WXXWY News and Press, Wuxi Biologics Cayman Inc ADR

2026-02-13 05:45:00 ET The following segment was excerpted from the Baird International And Global Growth Funds Q4 2025 Commentary And Market Outlook. ... Read the full article on Seeking Alpha For further details see: Baird Chautauqua In...

WuXi Biologics Awarded EcoVadis Platinum Medal for Third Consecutive Year, Ranking Among Top 1% Globally PR Newswire SHANGHAI , Feb. 8, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), announced it has been awarded a Platinum Medal by the EcoVadis Sustainability Rating, ma...

WuXi Biologics and Vertex Sign License and Research Service Agreement for T-cell Engager PR Newswire SHANGHAI , Feb. 2, 2026 /PRNewswire/ -- WuXi Biologics (2269. HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced tha...

2026-01-29 12:17:19 ET More and more it feels like companies across industries have bought into the idea that it is often best to specialize in whatever it is they do best and outsource as much of what remains as is practical. In the case of pharmaceutical and biotech companies (“bio...

WuXi Biologics and Sinorda Biomedicine Enter Strategic Collaboration to Accelerate Development and Manufacturing of Innovative Bispecific Antibody PR Newswire SHANGHAI , Jan. 28, 2026 /PRNewswire/ -- WuXi Biologics ( 2269.HK ), a leading global Contract Research, Development,...

JPM Highlights | WuXi Biologics CEO Dr. Chris Chen: Scaled CRDMO Platform Delivering Sustainable High Growth PR Newswire Total of 945 integrated projects in 2025, including 74 Phase III clinical projects and 25 commercial manufacturing projects 209 new integrated projects in 2025 ...

2026-01-14 20:05:58 ET WuXi Biologics (Cayman) Inc. (WXXWY) 44th Annual J.P. Morgan Healthcare Conference January 14, 2026 11:15 AM EST... Read the full article on Seeking Alpha For further details see: WuXi Biologics (Cayman) Inc. (WXXWY) Presents at 44th Annual J.P. Morgan...

WuXi Biologics Obtains GMP Certification from UK MHRA for Commercial Manufacturing of an Ophthalmic Biologic PR Newswire WUXI, China , Jan. 12, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization ...

WuXi Biologics Launches Industry-Leading Digital Twin Platform PatroLab™ Designed to Transform Bioprocessing and Manufacturing PR Newswire SHANGHAI , Jan. 12, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufactur...

WuXi Biologics Achieves ISO 20400 Certification, Setting Benchmark in Sustainable Procurement PR Newswire WUXI, China , Jan. 4, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK) announced it has achieved ISO 20400 Sustainable Procurement certification, an internationally recogniz...